Literature DB >> 22471496

Frequent incidence of double minute chromosomes in cancers, with special up-to-date reference to leukemia.

Abolfazl Movafagh1, Reza Mirfakhraei, Alireza Mousavi-Jarrahi.   

Abstract

Double minute chromosomes (DMs) are small chromatin bodies consisting of gene amplification in an extrachromosomal location. Although found in an variety of human tumor cells, their presence in hematologic malignancies is rare and their role in leukemogenesis is controversial. However, they are thought to be involved in tumorigenesis and in drug resistance, representing a mechanism for upregulated oncogene expression generally associated with a poor prognosis. The presence of DMs has been associated with a rapid disease course, low response rate, and short survival. Little knowledge is, however, available on DMs in leukemias. To elucidate this issue, a web-based search for all types of articles published was initiated using MEDLINE/PubMed, the Mitelman database and other pertinent references on websites. We found that DMs have the highest frequency in adrenal carcinoma (28.6%), and lowest rate noted as 2.6% for large intestine. The large Mitelman database and other web based pertinent reports provide novel knowledge of DMs and their association in the wide field of cancers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22471496

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  4 in total

1.  FLT3 Amplification as Double Minute Chromosomes in a Patient with Chronic Myelomonocytic Leukemia.

Authors:  Heyang Zhang; Xiaoxue Wang; Shibo Li; Xianfu Wang; Xianglan Lu; Ming Li; Hua Wang; Ying Liu; Hui Pang; Lijun Zhang
Journal:  Dis Markers       Date:  2021-06-05       Impact factor: 3.434

2.  Identification of homogeneously staining regions in leukemia patients.

Authors:  Mohammad Heydarian Moghadam; Abolfazl Movafagh; Mirdavood Omrani; Kiandokht Ghanati; Mehrdad Hashemi; Farhikhteh Poursafavi; Hossein Darvish; Davood Zare Abdolahi; Milad Gholami; Mohammad Reza Heidari Rostamy; Shamsi Safari; Leyla Haghnejad; Reyhaneh Darehgazani; Niloofar Safavi Naeini; Mehdi Ghandehari Motlagh; Davar Amani
Journal:  J Res Med Sci       Date:  2013-04       Impact factor: 1.852

3.  Lack of Altered BECN1 Gene Expression in Iranian Patients with Acute Myeloid Leukemia

Authors:  Ladan Keyvan; Seyed Kazem Bidoki; Davood Zare Abdollahi; Neda Mansouri; Mehrdad Hashemi; Sa Mortazavi Tabatabaei; Hediyeh Fardmanesh; Mansour Meimandi; Seyed Majid Ayatollahi; Hasan Jalaeikhoo; Abolfazl Movafagh
Journal:  Asian Pac J Cancer Prev       Date:  2016-12-01

4.  Molecular Diagnostics with Laboratory Finding in Patients with Myeloproliferative Neoplasms.

Authors:  Zahra Makani; Sina Mirzaahmadi; Marzieh Motallebi; Abolfazl Movafagh
Journal:  Iran J Public Health       Date:  2017-11       Impact factor: 1.429

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.